Stock·NASDAQ·Technology
CoreWeave Inc. (CRWV)
- Market cap
- $33.86B
- Dividend yield
- 0.00%
- Street target
- $147.50median of 42 analysts
- 52-week range
- $59.51 $141.79
The short version
Where CRWV stands today, in four lines, and what CleaRank Financial AI makes of it.
CRWV at a glance
CoreWeave Inc. (CRWV): Sell, 40/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($87.03 and $92.44).
- Earnings CRWV beat estimates in 2 of its last 5 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $10.6B and made no open-market purchases over the last 18 months.
Figures as of October 17, 2026.
CleaRank Financial AI
CoreWeave Inc. (CRWV) carries a CleaRank rating of Sell and a model score of 40/100.
The analysts' outlook gives the score its biggest lift, with 31 of 42 analysts rating it a buy and the median target 140.3% above the price. The trend is the largest drag: the price is 33.59% below its 200-day average and 29.46% below its 50-day, and the 50-day sits 5.85% below the 200-day. The 50-day average is $87.03 and the 200-day is $92.44. Across the past year, the price has fallen 56.69%.
Only on CleaRank
Figures we compute ourselves from CRWV's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $61.39 is 29.5% below the 50-day simple moving average of $87.03.Price above its 200-day average ›
The price is 33.6% below the 200-day simple moving average of $92.44.50-day average above the 200-day ›
The 50-day average ($87.03) is 5.8% below the 200-day average ($92.44), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 2% of its 52-week range, between $59.51 and $141.79.
CRWV share price
Pick a period: each tab shows how far CRWV has moved over it, to the last close.
Today's trading
Where CRWV sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/3P/S below the sector median ›
The price-to-sales ratio of 4.46 is 41.3% below the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $-1.9B on revenue of $7.6B, a net margin of -25.4%.Beat estimates in most recent reports ›
CRWV beat the EPS estimate in 2 of its last 5 reports.
Key statistics
The headline figures for CRWV.
As of October 17, 2026, CRWV trades at $61.39, with a market value of $33.86B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of CRWV's valuation, growth and risks.
CoreWeave Inc. (CRWV) has no meaningful P/E, because the company lost money over the last 12 months. Against that, its price-to-sales ratio of 4.46 is 41.3% below the sector median of 7.6. The company's market capitalisation stands at $33.9B.
The company is losing money, with a net margin of -25.40% and an operating margin of -1.90%. Growth outpaces the sector: revenue grew 112.50% in the latest year, against a sector median of 24.2%. It reports a return on equity of -43.60%, below the sector median of 13.4%. Rounding out the fundamentals, CRWV reports debt-to-equity of 10.27.
CRWV's latest report, dated August 11, 2026, came in ahead of expectations: it beat the estimate by 22.45%, with earnings of -$1.14 a share versus a -$1.47 estimate. Investors responded, and the stock rose 19.28% in the following session.
Across the last 5 reports, the company beat estimates in 2 of them. Those beats did not guarantee a gain, since the stock fell the next session after 1 of those 2 beats. For this fiscal year, analysts expect an average EPS of -$5.11, and -$4.33 for next year.
CRWV typically moves about 5.39% in a day. The trend is a headwind for holders until the price climbs back above its moving averages. For reference, the price is 56.70% below the 52-week high of $141.79.
CRWV against the Technology sector
How CRWV compares with the median Technology stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, CRWV trades at 4.46x, -41% versus the sector average of 7.60x.
Return vs XLK: Since May 6, 2025, CRWV has gained 13.1% against a gain of 71.7% for XLK.
Performance against XLK
CRWV and the Technology sector fund over the same days.
Revenue and earnings
How much CRWV sells, and how much of it becomes profit.
Revenue growth: Revenue grew 167.9% in FY2025 to $5.1B, from $1.9B a year earlier.
Profit margin: The net margin was -22.7% in FY2025, up from -45.1% the year before.
Loss-making: CRWV lost $1.2B in FY2025.
Earnings reality check
Did CRWV beat what analysts expected, and how did the stock react?
Earnings record: CRWV beat the analyst estimate in 2 of the last 5 quarters.
Market reaction: The stock fell in the first session after 1 of those 2 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 11, 2026after close | -$1.47 | -$1.14 | +22.45% | +19.28% | +3.16% |
| Feb 26, 2026after close | -$0.68 | -$0.89 | -30.88% | -18.51% | -23.36% |
| Nov 10, 2025after close | -$0.48 | -$0.22 | +54.17% | -16.31% | -28.67% |
| Aug 12, 2025after close | -$0.49 | -$0.60 | -22.45% | -20.83% | -37.55% |
| May 14, 2025after close | -$0.22 | -$1.40 | -536.36% | -2.51% | +59.19% |
As of October 17, 2026, CRWV has beaten the analyst EPS estimate in 2 of its last 5 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on August 11, 2026, came in 22.45% above the estimate and the stock moved +19.28% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
0/3RSI not overbought or oversold ›
The 14-day RSI is 29.5, in oversold territory.RSI above 50 ›
An RSI of 29.5 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of CRWV
The score, the reasoning behind it, and what could move the price next.
CoreWeave Inc. (CRWV) is in a downtrend: at $61.39, it trades 29.46% below its 50-day average of $87.03 and 33.59% below its 200-day average of $92.44. The price sits near the bottom of its 52-week range, 3.16% above the low of $59.51 and 56.70% below the high of $141.79. The 50-day average runs 5.85% below the 200-day average, so the shorter trend is weaker than the longer one.
The 14-day RSI of 29.5 is in oversold territory, and the MACD line is negative. The record is negative across every period shown: the price fell 16.15% over the past three months, fell 47.46% over the past six months and fell 56.69% over the past year. Volume in the last session ran 81.6% above its average, on a day the price fell 11.91%.
Earnings beat ›
The August 11, 2026 report beat the EPS estimate by 22.45%, and the share price rose 19.28% in the first session after it.
Source: Earnings report, August 11, 2026Analyst upgrade ›
JP Morgan upgraded it to Overweight from Neutral on September 24, 2026.
Source: Analyst action, JP Morgan, September 24, 2026
New analyst coverage ›
William Blair started coverage at Outperform on September 30, 2026.
Source: Analyst action, William Blair, September 30, 2026
- The two closest levels to watch are the 20-day EMA at $80.06, which sits above the price, and the 52-week low at $59.51, which sits below it.
- The 14-day RSI is 29.5, which is in the oversold zone, and the MACD line is negative. Readings above 70 or below 30 signal stretched momentum.
- In the first session after the August 11, 2026 report, the share price climbed 19.28%. CRWV has beaten estimates in 2 of the last 5 reports.
CRWV is priced under both its 50-day ($87.03) and 200-day ($92.44) averages, and that places the trend firmly down. A first sign of repair would be a move back above the 50-day. The closest level overhead is the 20-day EMA, at $80.06.
CRWV's next support below the price is the 52-week low at $59.51. Momentum has been heavily sold, with the RSI in oversold territory; a move back above that threshold would be an early hint of stabilisation.
Technical indicators
Momentum and trend for CRWV, from its daily closes.
As of October 17, 2026, with CRWV at $61.39, its 14-day RSI is 29.5 (oversold territory), its 50-day simple moving average is $87.03 and its 200-day is $92.44.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What CRWV moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, CRWV's 1-year correlation of daily returns is +0.41 with S&P 500 (SPY), +0.46 with Nasdaq 100 (QQQ), +0.35 with Bitcoin (BTC) and +0.09 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
31 of 42 analysts rate it a buy or strong buy, 8 a hold and 3 a sell.Median target above the price ›
The median 12-month target of $147.50 is 140.3% above the price.More buy ratings than three months ago ›
31 of 42 rate it a buy now, against 26 of 37 three months ago.
CRWV Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 5, 2026 | Freedom Capital Markets | Maintains | Buy |
| Oct 2, 2026 | Cantor Fitzgerald | Reiterates | Overweight |
| Oct 1, 2026 | Rosenblatt | Maintains | Buy |
| Sep 30, 2026 | William Blair | Initiates | Outperform |
| Sep 30, 2026 | Freedom Capital Markets | Maintains | Buy |
| Sep 24, 2026 | JP Morgan | Upgrade | Overweight |
As of October 17, 2026, 42 Wall Street analysts cover CRWV: 31 rate it a buy or strong buy, 8 a hold and 3 a sell or strong sell. Their 12-month price targets range from $39.00 to $278.00, with a median of $147.50, 140.3% above the price of $61.39.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
CRWV trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
CRWV moves about 5.4% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much CRWV tends to move, against the market and on its own.
The long record
CRWV's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/3Average daily move under 2% ›
The price has moved 5.39% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 66.9%, from June 2025 to July 2026; the price is still 66.6% below that peak.Beat the S&P 500 since the chart begins ›
$10,000 invested in March 2025 is now worth $15,348, against $13,963 in the S&P 500 (SPY).
CRWV Drawdowns & Recovery
As of October 17, 2026, CRWV's worst peak-to-trough fall over the last 2 years with dividends reinvested was -66.9% (June 2025 to July 2026); it is still 66.6% below that peak.
From daily closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into CRWV in March 2025 is worth now, against the same amount in the S&P 500.
Against the market: CRWV beat the S&P 500 over this period: $15,348 against $13,963.
A $10,000 investment in CRWV in March 2025 would be worth about $15,348 today with dividends reinvested, compared with about $13,963 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to CRWV, and which have not.
Strongest month, May: an average of +71.59%.
Weakest month, November: an average of -42.12%.
This month, October: has averaged -2.44%. Past seasonality does not repeat on schedule.
Average return for each calendar month over the stored price history; treat short histories with caution.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in CRWV, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CRWV today could grow to about $24,367 by 2036 in the base case, with a 90th-percentile outcome near $184,863 and a 10th-percentile outcome around $3,212. Projections are statistical simulations, not guarantees.
CRWV Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $87.66 for CRWV by 2030 in the base case, from $61.39 today (1.4x over 4 years). The 10th-percentile path ends near $24.33. These are outcomes of a Monte Carlo simulation run on CRWV's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $35.36 | $67.11 | $127 | |
| 2028 | $29.64 | $73.36 | $182 | |
| 2029 | $26.43 | $80.19 | $243 | |
| 2030 | $24.33 | $87.66 | $316 | |
| 2031 | $22.87 | $95.83 | $402 |
Method: a lognormal simulation of CRWV's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. CRWV is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation.
Insider trading
What the people running the company have bought and sold.
CRWV insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought CRWV shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, CRWV insiders reported 364 open-market sales worth $10.6B and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | Nitin Agrawal
Chief Financial Officer
|
Sell | 3 | $266 |
| Oct 6, 2026 | Karen Boone
Director
|
Grant | 1.5K | - |
| Sep 29, 2026 | Michael N Intrator
Chief Executive Officer
|
Sell | 307.7K | $26.7M |
| Sep 29, 2026 | Michael N Intrator
Chief Executive Officer
|
Grant | 107.7K | - |
| Sep 22, 2026 | Michael N Intrator
Chief Executive Officer
|
Sell | 307.7K | $26.7M |
| Sep 22, 2026 | Nitin Agrawal
Chief Financial Officer
|
Sell | 55.8K | $4.8M |
| Sep 22, 2026 | Michael N Intrator
Chief Executive Officer
|
Grant | 107.7K | - |
| Sep 18, 2026 | Brian M Venturo
Officer and Director
|
Grant | 62.5K | - |
| Sep 18, 2026 | Brian M Venturo
Officer and Director
|
Grant | 62.5K | - |
| Sep 15, 2026 | Michael N Intrator
Chief Executive Officer
|
Sell | 307.7K | $25.2M |
| Sep 15, 2026 | Michael N Intrator
Chief Executive Officer
|
Grant | 107.7K | - |
| Sep 14, 2026 | Nitin Agrawal
Chief Financial Officer
|
Sell | 66.6K | $5.6M |
| Sep 14, 2026 | Margaret C. Whitman
Director
|
Grant | 1.2K | - |
| Sep 11, 2026 | Nitin Agrawal
Chief Financial Officer
|
Grant | 122.3K | - |
| Sep 8, 2026 | Michael N Intrator
Chief Executive Officer
|
Sell | 307.7K | $30.8M |
| Sep 8, 2026 | Kristen J Mcveety
General Counsel
|
Sell | 97.5K | $9.2M |
| Sep 8, 2026 | Chen Goldberg
Officer
|
Sell | 22.4K | $2.2M |
| Sep 8, 2026 | Michael N Intrator
Chief Executive Officer
|
Grant | 107.7K | - |
| Sep 8, 2026 | Kristen J Mcveety
General Counsel
|
Option | 97.5K | $53.6K |
| Sep 1, 2026 | Michael N Intrator
Chief Executive Officer
|
Sell | 307.7K | $25.1M |
| Sep 1, 2026 | Kristen J Mcveety
General Counsel
|
Sell | 156.0K | $12.7M |
| Sep 1, 2026 | Michael N Intrator
Chief Executive Officer
|
Grant | 107.7K | - |
| Sep 1, 2026 | Kristen J Mcveety
General Counsel
|
Option | 156.0K | $85.8K |
| Aug 26, 2026 | Kristen J Mcveety
General Counsel
|
Sell | 2.1K | $184.9K |
| Aug 25, 2026 | Michael N Intrator
Chief Executive Officer
|
Sell | 307.7K | $27.3M |
| Aug 25, 2026 | Nitin Agrawal
Chief Financial Officer
|
Sell | 5.5K | $488.3K |
| Aug 25, 2026 | Michael N Intrator
Chief Executive Officer
|
Grant | 107.7K | - |
| Aug 24, 2026 | Brannin Mcbee
Officer
|
Sell | 249.5K | $21.3M |
| Aug 24, 2026 | Brannin Mcbee
Officer
|
Sell | 500 | $42.8K |
| Aug 24, 2026 | Brannin Mcbee
Officer
|
Grant | 249.5K | - |
| Aug 20, 2026 | Michael N Intrator
Chief Executive Officer
|
Sell | 13.1K | $1.2M |
| Aug 20, 2026 | Nitin Agrawal
Chief Financial Officer
|
Sell | 10.1K | $924.5K |
| Aug 20, 2026 | Chen Goldberg
Officer
|
Sell | 8.6K | $792.7K |
| Aug 20, 2026 | Sachin Jain
Chief Operating Officer
|
Sell | 6.3K | $582.4K |
| Aug 20, 2026 | Brian M Venturo
Officer and Director
|
Sell | 5.9K | $542.0K |
| Aug 20, 2026 | Kristen J Mcveety
General Counsel
|
Sell | 4.0K | $365.7K |
| Aug 20, 2026 | Brannin Mcbee
Officer
|
Sell | 3.6K | $331.7K |
| Aug 20, 2026 | Jeffrey R Baker
Officer
|
Sell | 1.3K | $115.4K |
| Aug 20, 2026 | Nitin Agrawal
Chief Financial Officer
|
Grant | 19.5K | - |
| Aug 20, 2026 | Jeffrey R Baker
Officer
|
Grant | 2.4K | - |
| Aug 20, 2026 | Chen Goldberg
Officer
|
Grant | 16.7K | - |
| Aug 20, 2026 | Michael N Intrator
Chief Executive Officer
|
Grant | 23.4K | - |
| Aug 20, 2026 | Sachin Jain
Chief Operating Officer
|
Grant | 15.6K | - |
| Aug 20, 2026 | Brannin Mcbee
Officer
|
Grant | 8.0K | - |
| Aug 20, 2026 | Kristen J Mcveety
General Counsel
|
Grant | 7.7K | - |
| Aug 20, 2026 | Brian M Venturo
Officer and Director
|
Grant | 11.4K | - |
| Aug 18, 2026 | Michael N Intrator
Chief Executive Officer
|
Sell | 307.7K | $29.5M |
| Aug 18, 2026 | Michael N Intrator
Chief Executive Officer
|
Grant | 107.7K | - |
| Aug 17, 2026 | Brannin Mcbee
Officer
|
Sell | 194.0K | $20.6M |
| Aug 17, 2026 | Brannin Mcbee
Officer
|
Sell | 55.5K | $5.9M |
| Aug 17, 2026 | Chen Goldberg
Officer
|
Sell | 6.4K | $678.8K |
| Aug 17, 2026 | Brannin Mcbee
Officer
|
Sell | 500 | $53.0K |
| Aug 17, 2026 | Brannin Mcbee
Officer
|
Grant | 194.0K | - |
| Aug 17, 2026 | Brannin Mcbee
Officer
|
Grant | 55.5K | - |
| Aug 14, 2026 | Financial, L.l.c. Magnetar
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 307.1K | $33.4M |
| Aug 13, 2026 | Financial, L.l.c. Magnetar
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 1.9M | $213.8M |
| Aug 12, 2026 | Financial, L.l.c. Magnetar
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 2.1M | $231.6M |
| Aug 12, 2026 | Sachin Jain
Chief Operating Officer
|
Sell | 1 | $110 |
| Aug 11, 2026 | Michael N Intrator
Chief Executive Officer
|
Sell | 307.7K | $27.4M |
| Aug 11, 2026 | Michael N Intrator
Chief Executive Officer
|
Grant | 107.7K | - |
| Aug 10, 2026 | Brannin Mcbee
Officer
|
Sell | 197.0K | $17.7M |
| Aug 10, 2026 | Brannin Mcbee
Officer
|
Sell | 53.0K | $4.8M |
| Aug 10, 2026 | Sachin Jain
Chief Operating Officer
|
Sell | 13.6K | $1.3M |
| Aug 10, 2026 | Glenn H Hutchins
Director
|
Grant | 1.4K | - |
| Aug 10, 2026 | Brannin Mcbee
Officer
|
Grant | 52.5K | - |
| Aug 10, 2026 | Brannin Mcbee
Officer
|
Grant | 197.0K | - |
| Aug 7, 2026 | Sachin Jain
Chief Operating Officer
|
Grant | 33.8K | - |
| Aug 5, 2026 | Chen Goldberg
Officer
|
Sell | 25.6K | $2.3M |
| Aug 5, 2026 | Chen Goldberg
Officer
|
Grant | 37.5K | - |
| Aug 4, 2026 | Michael N Intrator
Chief Executive Officer
|
Sell | 307.7K | $28.2M |
| Aug 4, 2026 | Michael N Intrator
Chief Executive Officer
|
Grant | 107.7K | - |
| Aug 3, 2026 | Brannin Mcbee
Officer
|
Sell | 161.7K | $13.3M |
| Aug 3, 2026 | Brannin Mcbee
Officer
|
Sell | 44.6K | $3.7M |
| Aug 3, 2026 | Brannin Mcbee
Officer
|
Sell | 33.2K | $2.8M |
| Aug 3, 2026 | Brannin Mcbee
Officer
|
Sell | 10.5K | $881.1K |
| Aug 3, 2026 | Brannin Mcbee
Officer
|
Grant | 28.0K | - |
| Aug 3, 2026 | Brannin Mcbee
Officer
|
Grant | 52.5K | - |
| Aug 3, 2026 | Brannin Mcbee
Officer
|
Grant | 144.0K | - |
| Jul 29, 2026 | Jeffrey R Baker
Officer
|
Sell | 6.5K | $429.3K |
| Jul 29, 2026 | Jeffrey R Baker
Officer
|
Grant | 12.5K | - |
| Jul 28, 2026 | Michael N Intrator
Chief Executive Officer
|
Sell | 307.7K | $20.5M |
| Jul 28, 2026 | Michael N Intrator
Chief Executive Officer
|
Grant | 107.7K | - |
| Jul 27, 2026 | Brannin Mcbee
Officer
|
Sell | 237.0K | $16.8M |
| Jul 27, 2026 | Brannin Mcbee
Officer
|
Sell | 13.0K | $923.5K |
| Jul 27, 2026 | Brannin Mcbee
Officer
|
Grant | 237.0K | - |
| Jul 27, 2026 | Brannin Mcbee
Officer
|
Grant | 12.5K | - |
| Jul 21, 2026 | Michael N Intrator
Chief Executive Officer
|
Sell | 307.7K | $24.1M |
| Jul 21, 2026 | Michael N Intrator
Chief Executive Officer
|
Grant | 107.7K | - |
| Jul 20, 2026 | Brannin Mcbee
Officer
|
Sell | 194.5K | $14.6M |
| Jul 20, 2026 | Brannin Mcbee
Officer
|
Sell | 55.5K | $4.2M |
| Jul 20, 2026 | Glenn H Hutchins
Director
|
Grant | 516 | $37.8K |
| Jul 20, 2026 | Brannin Mcbee
Officer
|
Grant | 55.5K | - |
| Jul 20, 2026 | Brannin Mcbee
Officer
|
Grant | 194.0K | - |
| Jul 20, 2026 | Margaret C. Whitman
Director
|
Grant | 153 | $11.2K |
| Jul 14, 2026 | Michael N Intrator
Chief Executive Officer
|
Sell | 307.7K | $24.9M |
| Jul 14, 2026 | Michael N Intrator
Chief Executive Officer
|
Grant | 107.7K | - |
| Jul 13, 2026 | Brannin Mcbee
Officer
|
Sell | 197.0K | $16.7M |
| Jul 13, 2026 | Nitin Agrawal
Chief Financial Officer
|
Sell | 65.1K | $5.5M |
| Jul 13, 2026 | Brannin Mcbee
Officer
|
Sell | 53.0K | $4.5M |
| Jul 13, 2026 | Brannin Mcbee
Officer
|
Grant | 197.0K | - |
| Jul 13, 2026 | Brannin Mcbee
Officer
|
Grant | 52.5K | - |
| Jul 8, 2026 | Michael N Intrator
Chief Executive Officer
|
Sell | 369.5K | $30.8M |
| Jul 8, 2026 | Nitin Agrawal
Chief Financial Officer
|
Sell | 3 | $249 |
| Jul 7, 2026 | Michael N Intrator
Chief Executive Officer
|
Grant | 107.7K | - |
| Jul 6, 2026 | Brannin Mcbee
Officer
|
Sell | 197.0K | $17.0M |
| Jul 6, 2026 | Brannin Mcbee
Officer
|
Sell | 53.0K | $4.6M |
| Jul 6, 2026 | Kristen J Mcveety
General Counsel
|
Sell | 22 | $1.9K |
| Jul 6, 2026 | Karen Boone
Director
|
Grant | 1.5K | - |
| Jul 6, 2026 | Brannin Mcbee
Officer
|
Grant | 52.5K | - |
| Jul 6, 2026 | Brannin Mcbee
Officer
|
Grant | 197.0K | - |
| Jul 1, 2026 | Brian M Venturo
Officer and Director
|
Sell | 142.4K | $13.0M |
| Jul 1, 2026 | Brian M Venturo
Officer and Director
|
Grant | 203.7K | - |
| Jun 30, 2026 | Michael N Intrator
Chief Executive Officer
|
Sell | 386.3K | $37.7M |
| Jun 30, 2026 | Brannin Mcbee
Officer
|
Sell | 57.2K | $5.5M |
| Jun 30, 2026 | Nitin Agrawal
Chief Financial Officer
|
Sell | 4 | $383 |
| Jun 30, 2026 | Jeffrey R Baker
Officer
|
Sell | 4 | $383 |
| Jun 30, 2026 | Chen Goldberg
Officer
|
Sell | 4 | $383 |
| Jun 30, 2026 | Kristen J Mcveety
General Counsel
|
Sell | 4 | $383 |
| Jun 30, 2026 | Sachin Jain
Chief Operating Officer
|
Sell | 3 | $287 |
| Jun 30, 2026 | Nitin Agrawal
Chief Financial Officer
|
Grant | 7 | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.